跳至主要内容
临床试验/CTRI/2023/07/055151
CTRI/2023/07/055151已完成4 期

A Double Blind Study to Assess Efficacy of Add-on Acetyl-L-carnitine and Agmatine over Escitalopram in Major Depressive Disorder. - MDD

Dr. G Prasad Rao0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Participants with HAM-D 18 and above.
  • 2.Patients suffering from mild to severe depression.
  • 3.18–65 Years of age, of either gender.
  • 4.Participants with existing co-morbid condition like diabetes or hypertension are on standard treatment stable last from 6 months.
  • 5.Willing to give signed Informed Consent.

排除标准

  • 1.Patients suffering from bipolar affective disorder, any form of schizophrenia, tuberculosis, and sarcoidosis.
  • 2.Pregnant or lactating women.
  • 3.Known allergy, intolerance or contraindication to study medication.
  • 4.Women of childbearing potential not willing to utilize effective contraception. A negative human chorionic gonadotropin (HCG) pregnancy test is required.
  • 5.Patients who has high suicidal risk (MADRS >3)
  • 6. Patients who have significant medical disorders like hepatic insufficiency, uncontrolled diabetes, renal impairment.

研究者

发起方
Dr. G Prasad Rao

相似试验